Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes in Pakistan.
Microalbuminuria is a renal marker of general vascular endothelial damage and early atherosclerosis with adverse prognostic implications. It is associated with diabetes, insulin resistance, central adiposity and hypertension. The Microalbuminuria Prevalence Study (MAPS) aimed to assess the prevalence of microalbuminuria in consecutively-screened hypertensive adult patients with type 2 diabetes mellitus in 103 centres of ten Asian countries. Cross-sectional clinic-based epidemiological study. This is the sub-analysis of data collected from patients attending the OPD of Baqai Institute of Diabetology and Endocrinology in Pakistan. Patients attended one study visit with no follow-up. Patients with bacteriuria and haematuria were excluded. A total of 99 subjects were studied out of which 56.3% were females. Mean age was 49.9 +/- 10.8 years. The prevalence of macroalbuminuria and microalbuminuria was 9.09% and 24.2% respectively. In Pakistan the prevalence of diabetic kidney disease was high in diabetic hypertensive subjects which is alarming and indicates an impending pandemic of diabetic renal and cardiovascular disease in the region.